LEP and breast carcinoma: A moderate negative correlation was observed between leptin and adiponectin (r = −0.3539; p = 0.053); adiponectin is known to exert potent anti-tumour activities, whereas leptin exhibits pro-tumorigenic properties in breast cancer [20].